Understanding Cancer Season Two

Lecture Nine: PLC-y1-PKC

This lecture aims to review the variation in the structure and function of the adaptor protein phospholipase C (PLC) family. All PLCs have EF-hand domain, C2 domain, and catalytic X and Y autophosphorylation linkage.  Several ligands bind towards these receptors, for instance, hormones, growth factors, external stimuli, and neurotransmitters. The PLC is activated upon binding to the receptor-ligand (EGFR-EGF) complex. The lecture further provides insight into how secondary messengers, inositol triphosphate (IP3) and diacylglycerol (DAG) activated by PLC. Another protein, phospholipase D (PLD), and how it transduces the signal via protein kinase C (PKC) to elicit cellular response is mentioned. The causes of the dysregulation of the PLC-γ1-PKC pathway and the hallmarks of cancer and its effects are analyzed further by revealing the crosstalk between GPCR and PLC.


PLC-γ1-PKC pathway

EGFR is an example of a receptor transduced by phospholipase C (PLC-γ1) by binding to EGFR-EGF complexes. PLC then forms two secondary messengers, Diacylglycerol (purple; DAG) and inositol triphosphate (orange-yellow; IP3) hydrolyzing phosphatidylinositol-4, 5-bisphosphate (PI(4,5)P2) (orange; PIP2).  Diacylglycerol (DAG) activates protein kinase C (peach) and then phosphorylates downstream target cellular proteins for processes, for instance, cell growth, differentiation, and apoptosis. IP3 then interacts with another second messenger, calcium ions to release into the cytoplasm and induce transcription factor of target proteins. A larger size of the image can be found in the resource list.

Resource List For Lecture Nine

Youtube video

Glossary

Quiz

PDF formats of the images

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Leave a comment